NAGE
Price
$9.43
Change
+$0.11 (+1.18%)
Updated
Sep 5, 04:59 PM (EDT)
Capitalization
750.48M
53 days until earnings call
VIR
Price
$5.27
Change
+$0.13 (+2.53%)
Updated
Sep 5, 04:59 PM (EDT)
Capitalization
732.09M
54 days until earnings call
Interact to see
Advertisement

NAGE vs VIR

Header iconNAGE vs VIR Comparison
Open Charts NAGE vs VIRBanner chart's image
Niagen Bioscience
Price$9.43
Change+$0.11 (+1.18%)
Volume$15.95K
Capitalization750.48M
Vir Biotechnology
Price$5.27
Change+$0.13 (+2.53%)
Volume$16.73K
Capitalization732.09M
NAGE vs VIR Comparison Chart in %
Loading...
NAGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VIR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NAGE vs. VIR commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NAGE is a StrongBuy and VIR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (NAGE: $9.32 vs. VIR: $5.14)
Brand notoriety: NAGE and VIR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NAGE: 89% vs. VIR: 135%
Market capitalization -- NAGE: $750.48M vs. VIR: $732.09M
NAGE [@Biotechnology] is valued at $750.48M. VIR’s [@Biotechnology] market capitalization is $732.09M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.87B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NAGE’s FA Score shows that 1 FA rating(s) are green whileVIR’s FA Score has 1 green FA rating(s).

  • NAGE’s FA Score: 1 green, 4 red.
  • VIR’s FA Score: 1 green, 4 red.
According to our system of comparison, VIR is a better buy in the long-term than NAGE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NAGE’s TA Score shows that 5 TA indicator(s) are bullish while VIR’s TA Score has 6 bullish TA indicator(s).

  • NAGE’s TA Score: 5 bullish, 3 bearish.
  • VIR’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, both NAGE and VIR are a good buy in the short-term.

Price Growth

NAGE (@Biotechnology) experienced а -5.09% price change this week, while VIR (@Biotechnology) price change was +1.98% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.44%. For the same industry, the average monthly price growth was +9.94%, and the average quarterly price growth was +31.78%.

Reported Earning Dates

NAGE is expected to report earnings on Oct 29, 2025.

VIR is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (+2.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NAGE($750M) and VIR($732M) have the same market capitalization . NAGE YTD gains are higher at: 75.683 vs. VIR (-29.973). NAGE has higher annual earnings (EBITDA): 18.1M vs. VIR (-586.27M). VIR has more cash in the bank: 606M vs. NAGE (60.3M). NAGE has less debt than VIR: NAGE (3.29M) vs VIR (102M). NAGE has higher revenues than VIR: NAGE (116M) vs VIR (14.4M).
NAGEVIRNAGE / VIR
Capitalization750M732M102%
EBITDA18.1M-586.27M-3%
Gain YTD75.683-29.973-253%
P/E Ratio42.77N/A-
Revenue116M14.4M806%
Total Cash60.3M606M10%
Total Debt3.29M102M3%
FUNDAMENTALS RATINGS
NAGE vs VIR: Fundamental Ratings
NAGE
VIR
OUTLOOK RATING
1..100
2412
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
38
Fair valued
PROFIT vs RISK RATING
1..100
79100
SMR RATING
1..100
2598
PRICE GROWTH RATING
1..100
4061
P/E GROWTH RATING
1..100
10029
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VIR's Valuation (38) in the null industry is somewhat better than the same rating for NAGE (76) in the Chemicals Specialty industry. This means that VIR’s stock grew somewhat faster than NAGE’s over the last 12 months.

NAGE's Profit vs Risk Rating (79) in the Chemicals Specialty industry is in the same range as VIR (100) in the null industry. This means that NAGE’s stock grew similarly to VIR’s over the last 12 months.

NAGE's SMR Rating (25) in the Chemicals Specialty industry is significantly better than the same rating for VIR (98) in the null industry. This means that NAGE’s stock grew significantly faster than VIR’s over the last 12 months.

NAGE's Price Growth Rating (40) in the Chemicals Specialty industry is in the same range as VIR (61) in the null industry. This means that NAGE’s stock grew similarly to VIR’s over the last 12 months.

VIR's P/E Growth Rating (29) in the null industry is significantly better than the same rating for NAGE (100) in the Chemicals Specialty industry. This means that VIR’s stock grew significantly faster than NAGE’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NAGEVIR
RSI
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
74%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
73%
MACD
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 8 days ago
79%
Bullish Trend 3 days ago
74%
Declines
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 8 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
NAGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VIR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RTOUX43.250.64
+1.50%
Russell Inv Tax-Managed US Mid&Sm Cap M
LSVQX19.900.25
+1.27%
LSV Small Cap Value Institutional
ASCYX11.180.10
+0.90%
Alger Small Cap Growth Y
MITBX35.950.29
+0.81%
MFS Massachusetts Investors Tr B
AMRCX5.320.04
+0.76%
American Growth One C

NAGE and

Correlation & Price change

A.I.dvisor indicates that over the last year, NAGE has been loosely correlated with IRON. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if NAGE jumps, then IRON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NAGE
1D Price
Change %
NAGE100%
-3.62%
IRON - NAGE
45%
Loosely correlated
-2.27%
MDGL - NAGE
45%
Loosely correlated
-0.93%
EPRX - NAGE
34%
Loosely correlated
-0.74%
ADMA - NAGE
32%
Poorly correlated
+0.03%
VIR - NAGE
31%
Poorly correlated
-6.72%
More

VIR and

Correlation & Price change

A.I.dvisor indicates that over the last year, VIR has been loosely correlated with SANA. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if VIR jumps, then SANA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VIR
1D Price
Change %
VIR100%
-6.72%
SANA - VIR
64%
Loosely correlated
-0.33%
CPRX - VIR
46%
Loosely correlated
+0.05%
NRIX - VIR
42%
Loosely correlated
-3.59%
IRON - VIR
38%
Loosely correlated
-2.27%
SYRE - VIR
38%
Loosely correlated
+1.07%
More